REGENXBIO Inc. (NASDAQ:RGNX) Given Average Recommendation of “Moderate Buy” by Brokerages
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price […]
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price […]
